MassChallenge Launches Breakthrough Bio for Israel, Taiwan Startups, Backed by 2 Inaugural Partners
Updated
Updated · PR Newswire · Jul 29
MassChallenge Launches Breakthrough Bio for Israel, Taiwan Startups, Backed by 2 Inaugural Partners
1 articles · Updated · PR Newswire · Jul 29
Summary
Breakthrough Bio will connect biotech and medtech startups from Israel and Taiwan with U.S. investors, regulators, mentors and industry partners through a new MassChallenge commercialization program.
Early January 2027 marks the program’s start, with on-the-ground immersions in Boston-Cambridge, San Diego around LSI USA, and Philadelphia around the 2027 BIO International Convention.
July 29 opens applications for the Israel cohort, which close August 18; Taiwan’s cohort opens September 1 and closes October 16.
The Israel Innovation Authority and Taiwan’s Development Center for Biotechnology are the inaugural partners, reflecting MassChallenge’s push to bridge overseas science with U.S. market access.
Since 2009, MassChallenge has supported more than 5,000 startups that have raised over $27 billion, giving the new program an established platform as it seeks more government partners for 2027-28.